TELA Bio launches OviTex PRS Long-Term Resorbable for plastic and reconstructive surgery

TELA Bio, Inc.

OviTex PRS Long-Term Resorbable is intended for soft tissue repair or reinforcement in plastic and reconstructive surgery.
Product supplements existing OviTex PRS portfolio which includes Permanent and Short-Term Resorbable configurations.
Features include bi-directional stretch and a fully resorbable, long-term polymer for reinforcement.
OviTex PRS has over 6,800 implantations at more than 400 healthcare facilities.
CEO Antony Koblish says addition allows surgeons to address indications requiring longer term reinforcement without permanent materials.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.